Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer: results from a prospective phase IV clinical trial
Background - Older patients with metastatic pancreatic cancer may suffer increased toxicity from intensive chemotherapy. Treatment individualization by geriatric assessment (GA) might improve functional outcome. - Methods - We performed a multicenter, phase IV, open label trial in patients ≥70 years...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
June 2022
|
| In: |
Journal of geriatric oncology
Year: 2022, Volume: 13, Issue: 5, Pages: 662-666 |
| ISSN: | 1879-4076 |
| DOI: | 10.1016/j.jgo.2021.12.018 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jgo.2021.12.018 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1879406821006640 
|
| Author Notes: | Johannes Betge, Nadine Schulte, Sebastian Belle, Tianzuo Zhan, Beate Krammer-Steiner, Jean-Charles Moulin, Matthias Kleiß, Frank Lammert, Ulrich Wedding, Sebastian Räth, Martin Maenz, Lisa Hegele, Julian Larcher-Senn, Ralf Jesenofsky, Matthias P. Ebert, Nicolai Härtel |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1809931541 | ||
| 003 | DE-627 | ||
| 005 | 20240416193745.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220712s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jgo.2021.12.018 |2 doi | |
| 035 | |a (DE-627)1809931541 | ||
| 035 | |a (DE-599)KXP1809931541 | ||
| 035 | |a (OCoLC)1425217260 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Betge, Johannes |d 1986- |e VerfasserIn |0 (DE-588)108257421X |0 (DE-627)847674347 |0 (DE-576)455525021 |4 aut | |
| 245 | 1 | 0 | |a Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer |b results from a prospective phase IV clinical trial |c Johannes Betge, Nadine Schulte, Sebastian Belle, Tianzuo Zhan, Beate Krammer-Steiner, Jean-Charles Moulin, Matthias Kleiß, Frank Lammert, Ulrich Wedding, Sebastian Räth, Martin Maenz, Lisa Hegele, Julian Larcher-Senn, Ralf Jesenofsky, Matthias P. Ebert, Nicolai Härtel |
| 264 | 1 | |c June 2022 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 3 January 2022, Artikelversion: 17 June 2022 | ||
| 500 | |a Gesehen am 08.01.2024 | ||
| 520 | |a Background - Older patients with metastatic pancreatic cancer may suffer increased toxicity from intensive chemotherapy. Treatment individualization by geriatric assessment (GA) might improve functional outcome. - Methods - We performed a multicenter, phase IV, open label trial in patients ≥70 years with metastatic pancreatic adenocarcinoma. Patients underwent GA and were assigned to one of three categories based on their scores: Go-Go, Slow-Go, or Frail. These categories were intended to guide physician's treatment decisions when choosing to treat patients with nab-paclitaxel/gemcitabine (arm A), gemcitabine (arm B), or best supportive care (arm C). Primary objective was a stable (loss of five points or less) Barthel's Activities of Daily Living (ADL) score during chemotherapy; secondary endpoints included GA scores during therapy, safety, quality of life, response and survival rates. - Results - Thirty-two patients were enrolled in the trial in six centers in Germany (out of 135 planned), resulting in termination due to low recruitment. Fifteen patients were allocated to nab-paclitaxel/gemcitabine, fifteen to gemcitabine, and two to best supportive care by their physicians, although according to their GA scores 29 patients (91%) were categorized as Slow-Go and three (9%) as Go-Go. Thus, fifteen of 32 (47%) patients were misclassified and given a course of treatment inconsistent with their GA scores. Median progression-free survival (PFS) were 3.3 months and 9.1 months and median time to quality-of-life deterioration 13 days and 29 days in the nab-paclitaxel/gemcitabine and gemcitabine monotherapy arms, respectively. Serious adverse events were reported in 11 (78.6%) patients in the nab-paclitaxel/gemcitabine and 8 (53.3%) patients in the gemcitabine arm. - Conclusions - Clinical evaluations by investigators differed markedly from geriatric assessments, leading to potential overtreatment. In our modest sample size study, those patients undergoing more intensive therapy had a less favorable course. | ||
| 650 | 4 | |a Gemcitabine | |
| 650 | 4 | |a Geriatric assessment | |
| 650 | 4 | |a Geriatric oncology | |
| 650 | 4 | |a Nab-paclitaxel | |
| 650 | 4 | |a Older patients with cancer | |
| 650 | 4 | |a Pancreatic cancer | |
| 650 | 4 | |a Personalized medicine | |
| 700 | 1 | |a Schulte, Nadine |d 1981- |e VerfasserIn |0 (DE-588)138942404 |0 (DE-627)703158511 |0 (DE-576)308939069 |4 aut | |
| 700 | 1 | |a Belle, Sebastian |d 1976- |e VerfasserIn |0 (DE-588)134303415 |0 (DE-627)69224140X |0 (DE-576)278646646 |4 aut | |
| 700 | 1 | |a Zhan, Tianzuo |d 1985- |e VerfasserIn |0 (DE-588)1019998911 |0 (DE-627)691070105 |0 (DE-576)359019544 |4 aut | |
| 700 | 1 | |a Krammer-Steiner, Beate |d 1961- |e VerfasserIn |0 (DE-588)115408134 |0 (DE-627)077230493 |0 (DE-576)289865794 |4 aut | |
| 700 | 1 | |a Moulin, Jean-Charles |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kleiß, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lammert, Frank |d 1965- |e VerfasserIn |0 (DE-588)172862841 |0 (DE-627)697791890 |0 (DE-576)133718336 |4 aut | |
| 700 | 1 | |a Wedding, Ulrich |d 1964- |e VerfasserIn |0 (DE-588)132571943 |0 (DE-627)523955650 |0 (DE-576)299233006 |4 aut | |
| 700 | 1 | |a Räth, Sebastian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Maenz, Martin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hegele, Lisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Larcher-Senn, Julian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jesenofsky, Ralf |d 1960- |e VerfasserIn |0 (DE-588)1029758042 |0 (DE-627)734019238 |0 (DE-576)377606448 |4 aut | |
| 700 | 1 | |a Ebert, Matthias |d 1968- |e VerfasserIn |0 (DE-588)1030133522 |0 (DE-627)734827083 |0 (DE-576)377938432 |4 aut | |
| 700 | 1 | |a Härtel, Nicolai |d 1977- |e VerfasserIn |0 (DE-588)129912913 |0 (DE-627)483650609 |0 (DE-576)297899821 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of geriatric oncology |d Amsterdam [u.a.] : Elsevier Science, 2010 |g 13(2022), 5 vom: Juni, Seite 662-666 |h Online-Ressource |w (DE-627)627611915 |w (DE-600)2556813-9 |w (DE-576)336956584 |x 1879-4076 |7 nnas |a Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer results from a prospective phase IV clinical trial |
| 773 | 1 | 8 | |g volume:13 |g year:2022 |g number:5 |g month:06 |g pages:662-666 |g extent:5 |a Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer results from a prospective phase IV clinical trial |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jgo.2021.12.018 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S1879406821006640 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240108 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 129912913 |a Härtel, Nicolai |m 129912913:Härtel, Nicolai |d 60000 |d 61100 |e 60000PH129912913 |e 61100PH129912913 |k 0/60000/ |k 1/60000/61100/ |p 16 |y j | ||
| 998 | |g 1030133522 |a Ebert, Matthias |m 1030133522:Ebert, Matthias |d 60000 |d 61100 |e 60000PE1030133522 |e 61100PE1030133522 |k 0/60000/ |k 1/60000/61100/ |p 15 | ||
| 998 | |g 1029758042 |a Jesenofsky, Ralf |m 1029758042:Jesenofsky, Ralf |d 60000 |d 61100 |e 60000PJ1029758042 |e 61100PJ1029758042 |k 0/60000/ |k 1/60000/61100/ |p 14 | ||
| 998 | |g 1019998911 |a Zhan, Tianzuo |m 1019998911:Zhan, Tianzuo |d 60000 |d 61100 |e 60000PZ1019998911 |e 61100PZ1019998911 |k 0/60000/ |k 1/60000/61100/ |p 4 | ||
| 998 | |g 134303415 |a Belle, Sebastian |m 134303415:Belle, Sebastian |d 60000 |d 61100 |e 60000PB134303415 |e 61100PB134303415 |k 0/60000/ |k 1/60000/61100/ |p 3 | ||
| 998 | |g 138942404 |a Schulte, Nadine |m 138942404:Schulte, Nadine |d 60000 |d 61100 |e 60000PS138942404 |e 61100PS138942404 |k 0/60000/ |k 1/60000/61100/ |p 2 | ||
| 998 | |g 108257421X |a Betge, Johannes |m 108257421X:Betge, Johannes |d 60000 |d 61100 |e 60000PB108257421X |e 61100PB108257421X |k 0/60000/ |k 1/60000/61100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1809931541 |e 4450645715 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Johannes Betge, Nadine Schulte, Sebastian Belle, Tianzuo Zhan, Beate Krammer-Steiner, Jean-Charles Moulin, Matthias Kleiß, Frank Lammert, Ulrich Wedding, Sebastian Räth, Martin Maenz, Lisa Hegele, Julian Larcher-Senn, Ralf Jesenofsky, Matthias P. Ebert, Nicolai Härtel"]},"id":{"eki":["1809931541"],"doi":["10.1016/j.jgo.2021.12.018"]},"recId":"1809931541","physDesc":[{"extent":"5 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"627611915","disp":"Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer results from a prospective phase IV clinical trialJournal of geriatric oncology","origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"2010-","publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science"}],"pubHistory":["1.2010 -"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 24.02.11"],"id":{"zdb":["2556813-9"],"issn":["1879-4076"],"eki":["627611915"]},"part":{"year":"2022","volume":"13","pages":"662-666","extent":"5","text":"13(2022), 5 vom: Juni, Seite 662-666","issue":"5"},"title":[{"title":"Journal of geriatric oncology","title_sort":"Journal of geriatric oncology","subtitle":"cancer and aging research"}]}],"person":[{"given":"Johannes","role":"aut","family":"Betge","display":"Betge, Johannes"},{"role":"aut","given":"Nadine","family":"Schulte","display":"Schulte, Nadine"},{"family":"Belle","role":"aut","given":"Sebastian","display":"Belle, Sebastian"},{"given":"Tianzuo","role":"aut","family":"Zhan","display":"Zhan, Tianzuo"},{"display":"Krammer-Steiner, Beate","family":"Krammer-Steiner","role":"aut","given":"Beate"},{"role":"aut","given":"Jean-Charles","family":"Moulin","display":"Moulin, Jean-Charles"},{"family":"Kleiß","role":"aut","given":"Matthias","display":"Kleiß, Matthias"},{"family":"Lammert","role":"aut","given":"Frank","display":"Lammert, Frank"},{"display":"Wedding, Ulrich","family":"Wedding","given":"Ulrich","role":"aut"},{"display":"Räth, Sebastian","role":"aut","given":"Sebastian","family":"Räth"},{"display":"Maenz, Martin","given":"Martin","role":"aut","family":"Maenz"},{"family":"Hegele","role":"aut","given":"Lisa","display":"Hegele, Lisa"},{"role":"aut","given":"Julian","family":"Larcher-Senn","display":"Larcher-Senn, Julian"},{"display":"Jesenofsky, Ralf","family":"Jesenofsky","given":"Ralf","role":"aut"},{"display":"Ebert, Matthias","family":"Ebert","role":"aut","given":"Matthias"},{"given":"Nicolai","role":"aut","family":"Härtel","display":"Härtel, Nicolai"}],"origin":[{"dateIssuedDisp":"June 2022","dateIssuedKey":"2022"}],"title":[{"subtitle":"results from a prospective phase IV clinical trial","title":"Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer","title_sort":"Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer"}],"note":["Online verfügbar: 3 January 2022, Artikelversion: 17 June 2022","Gesehen am 08.01.2024"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} | ||
| SRT | |a BETGEJOHANNEGLECTEDG2022 | ||